Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Naoki Sakai is active.

Publication


Featured researches published by Naoki Sakai.


Genes, Chromosomes and Cancer | 2002

Comprehensive mutational analysis of the VHL gene in sporadic renal cell carcinoma: Relationship to clinicopathological parameters

Keiichi Kondo; Masahiro Yao; Minoru Yoshida; Takeshi Kishida; Taro Shuin; Takeshi Miura; Masatoshi Moriyama; Kazuki Kobayashi; Naoki Sakai; Shigeki Kaneko; Satoshi Kawakami; Masaya Baba; Noboru Nakaigawa; Yoji Nagashima; Yukio Nakatani; Masahiko Hosaka

To delineate more precisely the somatic von Hippel‐Lindau disease (VHL) gene alteration as well as to elucidate its etiologic role in renal tumorigenesis, we examined a total of 240 sporadic renal cell carcinomas (RCCs) for somatic VHL gene alterations by DNA‐SSCP followed by sequencing, methylation‐specific PCR assay, microsatellite LOH study, and Southern blot analysis. Intragenic mutation of the VHL gene was found exclusively in clear‐cell or variant‐type RCCs at a frequency of 51% (104/202). Hypermethylation of the VHL promoter region was detected in an additional 11 clear‐cell RCCs. Microsatellite analysis demonstrated that LOH of the VHL locus was found in 140/155 (90%) informative clear‐cell RCCs. The VHL gene therefore seems to be inactivated in a two‐hit manner by intragenic mutation or hypermethylation plus allelic loss in clear‐cell RCC. Genomic rearrangement of the VHL gene detected by Southern analysis was not found (0/216 cases); this is in contrast to germ lines in which Southern aberrations consisted of 7–19% of the mutations. Clinicopathologic data demonstrated that VHL mutation/LOH did not vary according to tumor progression in clear‐cell RCC, including tumor diameter, stage, grading, distant metastasis, and lymph node metastasis. Interestingly, VHL mutation was significantly less frequent in RCCs occurring in younger (≦ 55 years) than that in older (≧ 56 years) patients. These data suggested that the inactivation of the VHL tumor‐suppressor gene is a specific genetic change in clear‐cell RCC, and that it may occur at an early or first step in the clear‐cell tumorigenic pathway rather than as a late event.


International Journal of Cancer | 2001

PTEN/MMAC1/TEP1 mutations in human primary renal-cell carcinomas and renal carcinoma cell lines.

Keiichi Kondo; Masahiro Yao; Kazuki Kobayashi; Shinsuke Ota; Minoru Yoshida; Shigeki Kaneko; Masaya Baba; Naoki Sakai; Takeshi Kishida; Satoshi Kawakami; Hiroji Uemura; Yoji Nagashima; Yukio Nakatani; Masahiko Hosaka

Extensive allelotyping studies have implicated several tumor‐suppressor loci on chromosomes 3p, 5q, 6q, 8p, 9pq, 10q, 11q, 14q, 17p, 18q and 19p in human kidney tumorigenesis. The PTEN (also called MMAC1 and TEP1) gene, a candidate tumor suppressor located at chromosome 10q23.3, is mutated in a variety of sporadic malignancies as well as in patients with Cowden disease. To investigate the potential role of the PTEN gene in renal tumorigenesis, we searched for abnormalities of the gene in 68 primary renal‐cell carcinomas (RCCs) as well as in 17 renal carcinoma–derived cell lines, using DNA‐SSCP, sequencing and microsatellite analysis. Five of 68 (7.5%) primary RCCs exhibited intragenic mutations (3 missense, 1 deletion and 1 splice‐site), and 1 of 17 (5.9%) cell lines had an insertion mutation. Loss of heterozygosity of the PTEN gene occurred in 25% of primary RCCs, including the 3 cases with intragenic mutation and the 1 PTEN‐mutated cell line. Clinical and histopathological examinations revealed that 4 of the 5 primary tumors with PTEN mutation were high‐grade, advanced clear‐cell RCCs with distant metastases or renal vein tumor invasions, resulting in poor prognostic courses. The other was a low‐stage papillary/chromophilic RCC. Our data suggest that PTEN mutation is observed in a subset of RCCs and that, especially in clear‐cell RCCs, it occurs as a late‐stage event and may contribute to the invasive and/or metastatic tumor phenotype.


Oncogene | 2001

Tumor suppressor protein VHL is induced at high cell density and mediates contact inhibition of cell growth

Masaya Baba; Syu-ichi Hirai; Satoshi Kawakami; Takeshi Kishida; Naoki Sakai; Shigeki Kaneko; Masahiro Yao; Taro Shuin; Yoshinobu Kubota; Masahiko Hosaka; Shigeo Ohno

In spite of the general recognition of von Hippel-Lindau (VHL) as a tumor suppressor gene, the physiological and pathological importance of VHL protein in cell growth regulation and tumorigenesis remains unclear. Here we show that in normal human renal proximal tubule epithelial cells (RPTEC), the steady-state amount of VHL protein is strictly regulated by cell density. The cellular VHL content is more than 100-fold higher in dense cultures than in sparse cultures. The increase in VHL protein at high cell density was also observed for NIH3T3 fibroblasts, suggesting the generality of the phenomenon. The growth rates of renal cell carcinoma cells lacking an intact VHL gene and their derivatives with wild-type or mutant VHL expression vector do not differ significantly when they are growing in log-phase. Importantly, however, there is a difference when they reach confluency: cells lacking wild-type VHL grew continuously, while cells expressing exogenous VHL protein showed relatively limited cell growth. Using an ecdysone-inducible VHL expressing cell line, we also show that the growth inhibition at high cell density can be released by attenuating the VHL expression. Taken together, we propose that VHL protein functions as a growth suppressor at high cell density, and this might be the basis of the tumor suppressor function of VHL.


Pathology International | 2004

Pathological and molecular biological aspects of the renal epithelial neoplasms, up-to-date

Yoji Nagashima; Yoshiaki Inayama; Yasumasa Kato; Naoki Sakai; Hiroshi Kanno; Ichiro Aoki; Masahiro Yao

Renal neoplasms are not necessarily high in frequency, but they are characteristic in their heterogeneity and occasional association with systemic familial tumor syndromes and phacomatoses (e.g. clear cell renal cell carcinoma and von Hippel‐Lindau disease, Wilms tumor and aniridia, genitourinary malformation and mental retardation (so‐called, WAGR syndrome), and angiomyolipoma and tuberous sclerosis). Physicians and pathologists should take note of these syndromes and associated renal neoplasms because they have provided important clues to elucidate the mechanism of tumorigenesis concerning cancer‐suppressor genes. This review aims to present recent classification of renal parenchymal neoplasms based on their molecular biological characteristics, and future problems yet to be clarified.


Cancer Genetics and Cytogenetics | 1996

A case of chromophobe renal cell carcinoma associated with low chromosome number and microsatellite instability

Taro Shuin; Keiichi Kondo; Naoki Sakai; Shigeki Kaneko; Masahiro Yao; Yoji Nagashima; Hitoshi Kitamura; Mitsuaki A. Yoshida

Cytogenetic study in a case of a human chromophobe renal cell carcinoma revealed a hypodiploid chromosome number of 36 with loss of chromosomes 1, 2, 5, 6, 10, 13, 15, 17, 21, and X. The tumor DNA showed microsatellite instability in dinucleotide repeat microsatellite markers. This is the fourth case that has been fully karyotyped and showed a low chromosome number in a chromophobe renal cell carcinoma. Our data in the present study are consistent with those in the literature. It is suggested that human chromophobe renal cell carcinoma may possibly be characterized by tumor cells with low chromosome number or microsatellite instability.


Clinical & Experimental Metastasis | 2000

Inostamycin, an inhibitor of cytidine 5′-diphosphate 1,2-diacyl-sn-glycerol (CDP-DG): Inositol transferase, suppresses invasion ability by reducing productions of matrix metalloproteinase-2 and -9 and cell motility in HSC-4 tongue carcinoma cell line

Yuh Baba; Mamoru Tsukuda; Izumi Mochimatsu; Shigeru Furukawa; Hiroko Kagata; Yoji Nagashima; Naoki Sakai; Shinri Koshika; Masaya Imoto; Yasumasa Kato

Inostamycin is an inhibitor of cytidine 5′-diphosphate 1,2-diacyl-sn-glycerol (CDP-DG): inositol transferase. It significantly reduced epidermal growth factor (EGF)-induced in vitro invasion of the tongue carcinoma cell line, HSC-4, through reconstituted basement membrane Matrigel®. Since phosphatidylinositol (PI) 4,5-biphosphate is important for signal transduction through protein kinase C and actin reorganisation, we further examined the effect of inostamycin on production of two matrix metalloproteinases (MMPs), MMP-2 and -9, and on cell motility. Zymographic analysis showed that inostamycin suppressed pro-MMP-2 and pro-MMP-9 levels at a dose-dependent fashion, while MMP-2 activity was not significantly affected. By reverse transcription-polymerase chain reaction, it was found that inostamycin diminished steady state levels of MMP-2 and -9 but not membrane type 1-MMP mRNA expressions. Inostamycin partially blocked both EGF- and phorbol 12-myristate 13-acetate-stimulated pro-MMP- 9 production. A cytoplasmic calcium chelator (BAPTA-AM) dramatically elevated pro- MMP-9 and slightly elevated pro-MMP-2 secretions. EGF-stimulated motility of HSC-4 cells was suppressed by inostamycin treatment along with reduction of actin cytoskeletal reorganisation, filopodia formation and cdc42 expression. These results suggested that inostamycin would be useful for an anti-invasive agent in tongue cancer.


The Journal of Pathology | 1996

Von Hippel-Lindau tumour suppressor gene. Localization of expression by in situ hybridization.

Yoji Nagashima; Yohei Miyagi; Kaori Udagawa; Atsuko Taki; Kazuaki Misugi; Naoki Sakai; K Kondo; Shigeki Kaneko; Masahiro Yao; Taro Shuin

Inactivation of the von Hippel–Lindau (VHL) tumour suppressor gene is responsible not only for VHL disease, but also for sporadic renal cell carcinoma and cerebellar haemangioblastoma. The distribution of VHL gene expression in the mouse embryo was recently studied by in situ hybridization, along with human VHL in 14‐week‐old fetal kidney: there was widely distributed expression in the former and expression in the tubules and blastema in the latter. Adult human tissue and other fetal organs were not examined. The present paper describes an in situ hybridization study to assess the function of the VHL gene in adult human tissues and in tissues of human fetus at 28 weeks of gestation. The expression of the VHL gene was limited to the adult and fetal brain and kidney, and the adult prostate. Nerve cells in adult and fetal brain were positive, including the cerebellar Purkinje cells. In adult and fetal kidney, the proximal tubular epithelium, the putative origin of the common type of renal cell carcinoma, showed intense signal, whereas the distal nephron, glomeruli, and nephrogenic blastema showed no significant signal. The prostate showed significant signal in the basal epithelium. The adrenal, pancreas, and epidydimis showed no significant signal, in spite of the frequent occurrence at these sites of neoplastic or hamartomatous lesions in VHL disease.


International Journal of Urology | 2001

Role of the diurnal variation of urinary pH and urinary calcium in urolithiasis: A study in outpatients

Tetsuo Murayama; Naoki Sakai; Tetsuo Yamada; Tetsuzou Takano

Abstract Background: We previously reported that the urinary excretion of calcium and the diurnal variation of urinary pH were important for stone formation in hospitalized inpatients with hospital standard diet. Because almost all urinary stones are formed in outpatients with ambulatory free diet, it is essential to investigate these factors in outpatients.


International Journal of Urology | 2000

Bilateral testicular tumors in androgen insensitivity syndrome.

Naoki Sakai; Tetsuo Yamada; Takeshi Asao; Masaya Baba; Minoru Yoshida; Tetsuo Murayama

We report on a case of complete androgen insensitivity syndrome with bilateral testicular tumors and a point mutation in the androgen receptor gene. A bilateral gonadecotmy was performed and both of the resected tumors were histologically diagnosed as pure seminoma. Direct sequencing of amplified exons E–G of the androgen receptor gene from the resected tumor identified a CGA to CAA substitution in exon E, resulting in arginine to glutamine replacement at codon 752. To our knowledge, this is the first reported case of androgen insensitivity syndrome with bilateral testicular tumors.


International Journal of Urology | 2001

Sonographically detected malignant transformation of a simple renal cyst

Naoki Sakai; Fumiyoshi Kanda; Keiichi Kondo; Hiroshi Fukuoka; Toru Tanaka

Abstract The clinical course is reported of a simple renal cyst which developed into a septated renal cyst, and finally to a cystic renal cell carcinoma. A 49‐year‐old man, who had been diagnosed as having a renal cyst, was found by repeated ultrasonography over 6 years to have solid components developing within the cyst. Radical nephrectomy was performed, and pathological examination confirmed cystic renal cell carcinoma (RCC). This case clearly shows a natural history of malignant transformation from a simple renal cyst, and emphasizes that careful follow‐up of renal cysts, especially of complicated renal cysts, is mandatory for successful treatment of RCC.

Collaboration


Dive into the Naoki Sakai's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Masahiro Yao

Yokohama City University

View shared research outputs
Top Co-Authors

Avatar

Noguchi S

Yokohama City University

View shared research outputs
Top Co-Authors

Avatar

Yoji Nagashima

Yokohama City University

View shared research outputs
Top Co-Authors

Avatar

Shigeki Kaneko

Yokohama City University

View shared research outputs
Top Co-Authors

Avatar

Keiichi Kondo

Yokohama City University

View shared research outputs
Top Co-Authors

Avatar

Kimito Osaka

Yokohama City University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Minoru Yoshida

Yokohama City University

View shared research outputs
Top Co-Authors

Avatar

Yusuke Ito

Yokohama City University

View shared research outputs
Researchain Logo
Decentralizing Knowledge